These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6943684)
41. Acute myeloblastic leukemia and sarcoidosis. Implications for pathogenesis. Reich JM Cancer; 1985 Jan; 55(2):366-9. PubMed ID: 3855267 [TBL] [Abstract][Full Text] [Related]
42. Down syndrome and acute myeloid leukemia. Lessons learned from experience with high-dose Ara-C containing regimens. Ravindranath Y; Taub JW Adv Exp Med Biol; 1999; 457():409-14. PubMed ID: 10500816 [No Abstract] [Full Text] [Related]
43. [Letter: Acute myeloblastic leukemia: prevision of the efficiency by the combination of daunorubicin-cytosine-arabinoside]. Zittoun R Nouv Presse Med; 1975 Jun; (23):1733. PubMed ID: 1099534 [No Abstract] [Full Text] [Related]
45. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine. Erikci AA; Ozturk A; Tekgunduz E; Sayan O Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372 [TBL] [Abstract][Full Text] [Related]
46. Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. Abu-Zahra H; Clarysse A; Cowan DH; Hasselback R; Bergsagel DE Can Med Assoc J; 1972 Dec; 107(11):1073-8. PubMed ID: 4509017 [TBL] [Abstract][Full Text] [Related]
47. Acute myeloblastic leukemia during pregnancy. Au-Yong R; Collins P; Young JA Br Med J; 1972 Nov; 4(5838):493-4. PubMed ID: 4510817 [No Abstract] [Full Text] [Related]
48. [Rubidomycin-daunomycin therapy in acute myeloblastic leukemia]. Dano K; Nissen NI; Pedersen-Bjergaard J; Thiede T Nord Med; 1968 Oct; 80(44):1475-82. PubMed ID: 5247180 [No Abstract] [Full Text] [Related]
49. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside]. Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900 [No Abstract] [Full Text] [Related]
50. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot]. Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866 [No Abstract] [Full Text] [Related]
51. Painful lesions in a pancytopenic patient. White C Clin J Oncol Nurs; 2002; 6(1):47-9, 51. PubMed ID: 11842488 [No Abstract] [Full Text] [Related]
52. Myeloblastic leukemia and leukemic meningitis in a dog. Weller RE; Geissler M; Jain NC Mod Vet Pract; 1980 Jan; 61(1):42-6. PubMed ID: 6929032 [No Abstract] [Full Text] [Related]
53. Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience. Tavil B; Aytac S; Balci YI; Unal S; Kuskonmaz B; Yetgin S; Gurgey A; Tuncer M; Gumruk F; Uckan D; Cetin M Pediatr Hematol Oncol; 2010 Oct; 27(7):517-28. PubMed ID: 20677923 [TBL] [Abstract][Full Text] [Related]
54. [Cytosine arabinoside in the polychemotherapy of acute leukemia]. Mandelli F Minerva Med; 1972 Mar; 63(24):1436-44. PubMed ID: 4502506 [No Abstract] [Full Text] [Related]
56. [Cytosine arabinoside in the treatment of acute childhood leukemia: clinical contribution]. Masera G; Carnelli V; Uderzo C Haematologica; 1972; 57(7):397-409. PubMed ID: 4628586 [No Abstract] [Full Text] [Related]
57. [Treatment of acute myeloblastic leukemia]. Jacquillat C; Weil M; Gemon MF Therapeutique; 1973 Mar; 49(3):221-5. PubMed ID: 4517257 [No Abstract] [Full Text] [Related]
58. [High doses of cytosine arabinoside in the treatment of patients with acute relapsing or refractory leukemia]. Lobato-Mendizábal E; Ruiz-Argüelles GJ; Marín-López A Rev Invest Clin; 1989; 41(2):139-45. PubMed ID: 2675236 [TBL] [Abstract][Full Text] [Related]
59. [Cytosine-arabinoside in the treatment of acute leukemias]. Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321 [No Abstract] [Full Text] [Related]